Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17P for Preterm Birth Prevention in Nulliparous Women with Short Cervix
NCT00439374Phase 3Terminated
- Sponsor
- George Washington University Biostatistics Center
- Start
- Apr 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxyprogesterone caproate in preterm birth, sponsored by George Washington University Biostatistics Center. Started Apr 2007; status: terminated.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT00439374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439374.